172 related articles for article (PubMed ID: 21573702)
1. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
[TBL] [Abstract][Full Text] [Related]
2. Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition.
Kim JA; Kim MR; Kim O; Phuong NT; Yun J; Oh WK; Bae K; Kang KW
Food Chem Toxicol; 2012 Oct; 50(10):3625-34. PubMed ID: 22842120
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression.
Kim MR; Choi HS; Yang JW; Park BC; Kim JA; Kang KW
Mol Cancer Ther; 2009 Aug; 8(8):2163-71. PubMed ID: 19671742
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells.
Oh SJ; Kim O; Lee JS; Kim JA; Kim MR; Choi HS; Shim JH; Kang KW; Kim YC
Food Chem Toxicol; 2010 Nov; 48(11):3227-34. PubMed ID: 20804812
[TBL] [Abstract][Full Text] [Related]
6. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells.
Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA
Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.
Kim SK; Yang JW; Kim MR; Roh SH; Kim HG; Lee KY; Jeong HG; Kang KW
Free Radic Biol Med; 2008 Aug; 45(4):537-46. PubMed ID: 18539158
[TBL] [Abstract][Full Text] [Related]
10. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
[TBL] [Abstract][Full Text] [Related]
11. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
12. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
[TBL] [Abstract][Full Text] [Related]
13. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
Choi HK; Yang JW; Roh SH; Han CY; Kang KW
Endocr Relat Cancer; 2007 Jun; 14(2):293-303. PubMed ID: 17639045
[TBL] [Abstract][Full Text] [Related]
14. Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation.
Phuong NT; Lim SC; Kim YM; Kang KW
Cancer Lett; 2014 Aug; 351(1):91-9. PubMed ID: 24836190
[TBL] [Abstract][Full Text] [Related]
15. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
[TBL] [Abstract][Full Text] [Related]
16. Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells.
Kim MR; Choi HS; Heo TH; Hwang SW; Kang KW
Biochem Biophys Res Commun; 2008 May; 369(2):547-53. PubMed ID: 18294451
[TBL] [Abstract][Full Text] [Related]
17. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.
Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS
J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004
[TBL] [Abstract][Full Text] [Related]
18. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
Rajbhandari P; Finn G; Solodin NM; Singarapu KK; Sahu SC; Markley JL; Kadunc KJ; Ellison-Zelski SJ; Kariagina A; Haslam SZ; Lu KP; Alarid ET
Mol Cell Biol; 2012 Jan; 32(2):445-57. PubMed ID: 22064478
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
[TBL] [Abstract][Full Text] [Related]
20. The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.
Lucchetti C; Caligiuri I; Toffoli G; Giordano A; Rizzolio F
PLoS One; 2013; 8(2):e55355. PubMed ID: 23390529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
